UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The lancet oncology, ISSN 1470-2045, 05/2019, Volume 20, Issue 5, pp. 625 - 635
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 03/2009, Volume 27, Issue 9, pp. 1394 - 1400
Life Sciences & Biomedicine | Oncology | Science & Technology | Tumors of the respiratory system and mediastinum | Biological and medical sciences | Medical sciences | Tumors | Pneumology | Lung Neoplasms - genetics | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Lung Neoplasms - enzymology | Prospective Studies | Carcinoma, Non-Small-Cell Lung - genetics | Humans | Middle Aged | Young Adult | Aged, 80 and over | Adult | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Carcinoma, Non-Small-Cell Lung - enzymology | Mutation | Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 09/2019, Volume 381, Issue 12, pp. 1103 - 1113
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Atrial Fibrillation - drug therapy | Humans | Atrial Fibrillation - complications | Kaplan-Meier Estimate | Proportional Hazards Models | Male | Drug Therapy, Combination - adverse effects | Factor Xa Inhibitors - therapeutic use | Rivaroxaban - adverse effects | Atrial Fibrillation - mortality | Coronary Disease - complications | Factor Xa Inhibitors - adverse effects | Coronary Disease - therapy | Coronary Artery Bypass | Female | Aged | Aspirin - therapeutic use | Platelet Aggregation Inhibitors - therapeutic use | Percutaneous Coronary Intervention | Purinergic P2Y Receptor Antagonists - therapeutic use | Rivaroxaban - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Rivaroxaban | Treatment outcome | Usage | Safety and security measures | Atrial fibrillation | Analysis | Thrombolytic drugs | Drug therapy | Myocardial infarction | Hypertension | Cerebral infarction | Anticoagulants | Cardiac arrhythmia | Stroke | Coronary artery | Clinical trials | Cardiovascular disease | Angina | Thrombosis | Embolism | Fibrillation | Hemostasis | Coronary vessels | Safety | Heart diseases | Age | Vitamin K | Index Medicus | Abridged Index Medicus
Journal Article
Clinical cancer research, ISSN 1078-0432, 07/2009, Volume 15, Issue 13, pp. 4493 - 4498
non–small cell lung cancer | mutation | EGF receptor | gefitinib | Life Sciences & Biomedicine | Oncology | Science & Technology | Tumors of the respiratory system and mediastinum | Biological and medical sciences | Medical sciences | Antineoplastic agents | Pharmacology. Drug treatments | Pneumology | Lung Neoplasms - genetics | Lung Neoplasms - drug therapy | Carcinoma, Non-Small-Cell Lung - genetics | Humans | Middle Aged | Male | Treatment Outcome | Antineoplastic Agents - therapeutic use | Mutation - physiology | Genes, erbB-1 | Quinazolines - therapeutic use | Survival Analysis | Aged, 80 and over | Adult | Female | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Clinical Trials, Phase II as Topic | Index Medicus
Journal Article
Targeted oncology, ISSN 1776-2596, 3/2013, Volume 8, Issue 1, pp. 27 - 33
EGFR mutation | Nonsmall cell lung cancer (NSCLC) | Medicine & Public Health | Erlotinib | Oncology | EGFR-TKI | Gefitinib | Biomedicine general | Life Sciences & Biomedicine | Science & Technology | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Lung Neoplasms - enzymology | Carcinoma, Non-Small-Cell Lung - genetics | Humans | Lung Neoplasms - pathology | Randomized Controlled Trials as Topic | Protein Kinase Inhibitors - administration & dosage | Clinical Trials, Phase III as Topic | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Carcinoma, Non-Small-Cell Lung - drug therapy | Carcinoma, Non-Small-Cell Lung - enzymology | Mutation | Precision Medicine - methods | Chemotherapy | Genetic aspects | Epidermal growth factor | Algorithms | Lung cancer, Non-small cell | Cancer | Index Medicus | Review
Journal Article
Circulation journal : official journal of the Japanese Circulation Society, ISSN 1346-9843, 2015, Volume 79, Issue 5, pp. 991 - 999
Heart failure | Myoblast sheets | Regenerative therapy | Multicenter study | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Heart Failure - surgery | Autografts | Follow-Up Studies | Humans | Middle Aged | Heart Failure - physiopathology | Male | Stroke Volume | Myoblasts, Skeletal - transplantation | Myocardial Ischemia - complications | Myocardial Ischemia - physiopathology | Adult | Female | Aged | Chronic Disease | Heart Failure - etiology | Myocardial Ischemia - surgery | Index Medicus
Journal Article
Angewandte Chemie (International ed.), ISSN 1433-7851, 01/2020, Volume 59, Issue 1, pp. 479 - 486
terpenoids | total synthesis | cyclization | rearrangement | alkaloids | Aconitine - chemical synthesis | Aconitine - chemistry | Molecular Structure | Aconitine - analogs & derivatives | Humans | Aconitum - chemistry | Diterpenes | Forging | Synthesis | Potassium channels | Ring structures | Mercury | Index Medicus
Journal Article
Cancer science, ISSN 1347-9032, 03/2013, Volume 104, Issue 3, pp. 291 - 297
Life Sciences & Biomedicine | Oncology | Science & Technology | Lung Neoplasms - genetics | Receptor, Epidermal Growth Factor - genetics | Specimen Handling | Histocytological Preparation Techniques | Carcinoma, Non-Small-Cell Lung - genetics | Humans | Reagent Kits, Diagnostic - standards | Mutation | DNA Mutational Analysis - methods | Mutagenicity Tests - methods | Epidermal growth factor | Gene mutations | Genes | Lung cancer, Small cell | Genetic aspects | Lung cancer, Non-small cell | Cancer | Index Medicus | Review
Journal Article
The New England journal of medicine, ISSN 0028-4793, 06/2010, Volume 362, Issue 25, pp. 2380 - 2388
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Tumors of the respiratory system and mediastinum | Biological and medical sciences | General aspects | Medical sciences | Pneumology | Lung Neoplasms - genetics | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Carcinoma, Non-Small-Cell Lung - genetics | Humans | Middle Aged | Carboplatin - administration & dosage | Lung Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | Genes, erbB-1 | Carcinoma, Non-Small-Cell Lung - secondary | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Quinazolines - therapeutic use | Survival Analysis | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Female | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Mutation | Paclitaxel - administration & dosage | Chemotherapy | Patient outcomes | Dosage and administration | Gefitinib | Lung cancer, Non-small cell | Drug therapy | Cancer | Studies | Peptides | Pharmaceutical industry | Cancer therapies | Lung cancer | Index Medicus | Abridged Index Medicus
Journal Article
Chemical & pharmaceutical bulletin, ISSN 0009-2363, 2020, Volume 68, Issue 9, pp. 848 - 854
Drug addiction | Amitriptyline | Degradation products | Forensic science | Desipramine | Entropy | Clomipramine | Degradation | Imipramine | Antidepressants | Tricyclic antidepressants | Juices | Pharmacokinetics | Activation energy | Gastric juice | Entropy of activation | Structural analysis | Index Medicus
Journal Article